"
Team:Bielefeld-Germany/Human Practices/StrategicProcess
From 2012.igem.org
(→Strategic Process) |
(→Strategic Process) |
||
| Line 2: | Line 2: | ||
| - | == | + | ==Strategy Process== |
[[File:Bielefeld2012_strategyprocess_igemgermany.jpg|300px|thumb|right|All iGEM teams from Germany]] | [[File:Bielefeld2012_strategyprocess_igemgermany.jpg|300px|thumb|right|All iGEM teams from Germany]] | ||
| + | [[File:Bielefeld2012_strategyprocess_igemmeeting.jpg|300px|thumb|right|Meeting of iGEM teams from Germany]] | ||
On 28th of June 2012 the third yearly congress of the strategy process “[http://www.biotechnologie2020plus.de/ Biotechnologie 2020+]” took place in Berlin. The strategy process was initiated by the German [http://www.bmbf.de/ Federal Ministry of Education and Research] to gather ideas and information about new production processes and methods as well as new applications by supporting the cooperation of science and engineering. During the [http://www.biotechnologie2020plus.de/BIO2020/Navigation/DE/root,did=152728.html congress] the recently realized arrangements were presented and still existing problems and questions were discussed in workshops. Central aspects were inhibiting and supporting factors for the development and production of future biotechnology products. | On 28th of June 2012 the third yearly congress of the strategy process “[http://www.biotechnologie2020plus.de/ Biotechnologie 2020+]” took place in Berlin. The strategy process was initiated by the German [http://www.bmbf.de/ Federal Ministry of Education and Research] to gather ideas and information about new production processes and methods as well as new applications by supporting the cooperation of science and engineering. During the [http://www.biotechnologie2020plus.de/BIO2020/Navigation/DE/root,did=152728.html congress] the recently realized arrangements were presented and still existing problems and questions were discussed in workshops. Central aspects were inhibiting and supporting factors for the development and production of future biotechnology products. | ||
This year all eleven iGEM teams from Germany participated with some of its members at the congress of the strategy process. Each iGEM team was present with a poster about its project and the teams discussed their ideas with the participants of the congress. For the iGEM teams the heterogenous professions of the participants had a special use, because the projects were observed from different points of view. Furthermore a meeting with all iGEM teams took place in order to get in contact with, to discuss and to help each other. Especially for new teams this was a possibility to discuss not only problems concerning their project but also central questions of the competition and organizational concerns. One of the central topics of the meeting was Human Practices. In this connection the iGEM teams were considering about how it is possible to give the society a deeper understanding of synthetic biology. Therefore the final idea was to organize a commun day of action in all ten cities of the iGEM teams in order to inform and to discuss with the society. | This year all eleven iGEM teams from Germany participated with some of its members at the congress of the strategy process. Each iGEM team was present with a poster about its project and the teams discussed their ideas with the participants of the congress. For the iGEM teams the heterogenous professions of the participants had a special use, because the projects were observed from different points of view. Furthermore a meeting with all iGEM teams took place in order to get in contact with, to discuss and to help each other. Especially for new teams this was a possibility to discuss not only problems concerning their project but also central questions of the competition and organizational concerns. One of the central topics of the meeting was Human Practices. In this connection the iGEM teams were considering about how it is possible to give the society a deeper understanding of synthetic biology. Therefore the final idea was to organize a commun day of action in all ten cities of the iGEM teams in order to inform and to discuss with the society. | ||
Revision as of 09:03, 3 August 2012
Strategy Process
On 28th of June 2012 the third yearly congress of the strategy process “[http://www.biotechnologie2020plus.de/ Biotechnologie 2020+]” took place in Berlin. The strategy process was initiated by the German [http://www.bmbf.de/ Federal Ministry of Education and Research] to gather ideas and information about new production processes and methods as well as new applications by supporting the cooperation of science and engineering. During the [http://www.biotechnologie2020plus.de/BIO2020/Navigation/DE/root,did=152728.html congress] the recently realized arrangements were presented and still existing problems and questions were discussed in workshops. Central aspects were inhibiting and supporting factors for the development and production of future biotechnology products.
This year all eleven iGEM teams from Germany participated with some of its members at the congress of the strategy process. Each iGEM team was present with a poster about its project and the teams discussed their ideas with the participants of the congress. For the iGEM teams the heterogenous professions of the participants had a special use, because the projects were observed from different points of view. Furthermore a meeting with all iGEM teams took place in order to get in contact with, to discuss and to help each other. Especially for new teams this was a possibility to discuss not only problems concerning their project but also central questions of the competition and organizational concerns. One of the central topics of the meeting was Human Practices. In this connection the iGEM teams were considering about how it is possible to give the society a deeper understanding of synthetic biology. Therefore the final idea was to organize a commun day of action in all ten cities of the iGEM teams in order to inform and to discuss with the society.
